High dose treatment with angiotensin II receptor blocker in patients with hypertension: Differential effect of tissue protection versus blood pressure lowering

This publication has 28 references indexed in Scilit:

• The tissue renin-angiotensin-aldosterone system in diabetes mellitus.
  Current Hypertension Reports, 2004
• Hypertensive Myocardial Fibrosis and Diastolic Dysfunction
  Hypertension, 2004
• Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney DiseaseResults From the AASK Trial
  JAMA, 2002
• Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
  The Lancet, 2002
• Reduced Cardiovascular Morbidity and Mortality in Hypertensive Diabetic Patients on First-Line Therapy With an ACE Inhibitor Compared With a Diuretic/β-Blocker–Based Treatment Regimen
  Diabetes Care, 2001
• Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
  New England Journal of Medicine, 2001
• Association Between Arterial Stiffness and Atherosclerosis
  Stroke, 2001
• Impact of Aortic Stiffness on Survival in End-Stage Renal Disease
  Circulation, 1999
• Noninvasive Pulse Wave Analysis for the Early Detection of Vascular Disease
  Hypertension, 1995
• Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling.
  Hypertension, 1994